GlassScriptPhysician profile
Jennifer Joy Hamner
NPI 1841417110
$3,341.17
in general payments reported to CMS, 2019-2025
8 companies · $64.63 in 2025
The $64.63 reported for 2025 was less than what a typical Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) provider received nationally (typical 2025 total: $413).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $352 · 2021: $64.20 · 2022: $248 · 2023: $363 · 2024: $2,249 · 2025: $64.63.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,427 · Travel and Lodging: $1,250.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,427.10 |
| Travel and Lodging | $1,250.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $2,352.80 | 2023-2024 | Axonics, Bulkamid |
| Coloplast Corp | $348.13 | 2022-2024 | |
| Boston Scientific Corporation | $296.80 | 2019-2025 | Upsylon, Advantage System, Solyx Sis System |
| Astellas Pharma US INC | $113.82 | 2019 | |
| Medtronic, INC. | $88.50 | 2021-2025 | Altaviva |
| Medtronic USA, INC. | $78.04 | 2019 | |
| Caldera Medical, INC | $37.91 | 2022 | |
| Laborie Medical Technologies Corp. | $25.17 | 2024 | Eclipse |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Hamner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.